Videos / Finerenone for chronic kidney disease in type 2 diabetes
In this Product Explainer, Nephrologist Prof Sunil Badve explains the role of finerenone to delay progressive decline of kidney function in adults with chronic kidney disease (CKD) associated with Type 2 diabetes with albuminuria (7 mins).

Oral GLP1s – What GPs Need to Know

The New Oral Medications for Obesity – A Practical Guide for GPs

Menstrual Migraine

GLP1s and Muscle Mass – What Does the Evidence Show?

expert
Nephrologist; Program Lead, Cardiometabolic Trials, Renal and Metabolic Program, The George Institute for Global Health; Senior Staff Specialist Nephrologist, St George Hospital